Q4 2025 Concentra Group Holdings Parent Inc Earnings Call Transcript
Key Points
- Concentra Group Holdings Parent Inc (CON) exceeded the high end of their 2025 guidance for both revenue and adjusted EBITDA.
- The company reported a 15.9% year-over-year revenue growth in Q4 2025, reaching $539.1 million.
- Concentra's adjusted EBITDA increased by 22.9% in Q4 2025 compared to the same quarter in the previous year.
- The company achieved a 25% lower average total workers' compensation claims cost compared to non-Concentra providers.
- Concentra's patient satisfaction metrics are at all-time highs, indicating strong customer approval.
- Despite strong financial performance, Concentra faces challenges with the New York workers' compensation fee schedule, which remains below desired levels.
- The company incurred over $2 million in one-time integration costs due to the Nova transaction.
- General and administrative expenses as a percentage of revenue increased from 8.2% in 2024 to 9.4% in 2025.
- Concentra's free cash flow conversion remained stable, but the company faced significantly more cash interest expense in 2025 due to the IPO recap.
- The company anticipates incremental separation costs in 2026 as they finalize hiring related to their separation from Select Medical.
Good morning, thank you for joining us today for Concentra Group Holdings Parent Inc earnings conference call to discuss the fourth quarter and full year 2025 results. Speaking today are the company's Chief Executive Officer, Keith Newton, and the company's President and Chief Financial Officer, Matthew DiCanio. Management will give you an overview and then open the call for questions.
Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities, and other statements that refer to Concentra's plans, expectations, strategies, intentions, and beliefs.
You are hereby cautioned that these forward-looking statements may be affected by the important factors, among others, set forth in Concentra's earnings release and in reports that are filed or furnished to the SEC. Consequently, actual operations and results may differ materially from those discussed in the forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

